Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Berdah

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 15, 2017
FAM13A is a modifier gene of cystic fibrosis lung phenotype regulating rhoa activity, actin cytoskeleton dynamics and epithelial-mesenchymal transitionHarriet Corvol, Nathalie Rousselet, Kristin E Thompson, et al.
Thorax|November 1, 2019
Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhageMarie-Louise Frémond, Marie Legendre, Michael Fayon, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 15, 2017
FAM13A is a modifier gene of cystic fibrosis lung phenotype regulating rhoa activity, actin cytoskeleton dynamics and epithelial-mesenchymal transitionHarriet Corvol, Nathalie Rousselet, Kristin E Thompson, et al.
Thorax|November 1, 2019
Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhageMarie-Louise Frémond, Marie Legendre, Michael Fayon, et al.
Pageof 2